Articles

Relationship between asthma drug therapy patterns and healthcare utilization

TI Shireman, PC Heaton, WE Gay, RJ Cluxton, and CJ Moomaw
Ann Pharmacother 2002;36:557-564. DOI 10.1345/aph.1A067 [Abstract] [PDF] [Order Reprint]  

Intravenous versus oral corticosteroids for treatment of acute asthma exacerbations

PP Fulco, AA Lone, and CB Pugh
Ann Pharmacother 2002;36:565-570. DOI 10.1345/aph.1A107 [Abstract] [PDF] [Order Reprint]  

Pharmacy-based bone mass measurement to assess osteoporosis risk

ME Elliott, PD Meek, NL Kanous, GR Schill, PA Weinswig, JP Bohlman, CL Zimpel, BC Jensen, DR Walters, SL Sutter, AN Peterson, RM Peterson, and NC Binkley
Ann Pharmacother 2002;36:571-577. DOI 10.1345/aph.1A299 [Abstract] [PDF] [Order Reprint]  

Discontinuing or switching selective serotonin-reuptake inhibitors

SA Bull, EM Hunkeler, JY Lee, CR Rowland, TE Williamson, Schwab, JR, and SW Hurt
Ann Pharmacother 2002;36:578-584. DOI 10.1345/aph.1A254 [Abstract] [PDF] [Order Reprint]  

Collaborative care model to improve outcomes in major depression

DM Boudreau, KL Capoccia, SD Sullivan, DK Blough, AJ Ellsworth, DL Clark, WJ Katon, EA Walker, and NG Stevens
Ann Pharmacother 2002;36:585-591. DOI 10.1345/aph.1A259 [Abstract] [PDF] [Order Reprint]  

Hyperlipidemia in HIV-positive patients receiving antiretrovirals

M Segarra-Newnham
Ann Pharmacother 2002;36:592-595. DOI 10.1345/aph.1A199 [Abstract] [PDF] [Order Reprint]  

A decade of antimicrobial susceptibilities at the University of Kentucky Hospital

RP Rapp, JA Ribes, SB Overman, TE Darkow, and ME Evans
Ann Pharmacother 2002;36:596-604. DOI 10.1345/aph.1A249 [Abstract] [PDF] [Order Reprint]  

The economic burden of Barrett's esophagus in a Medicaid population

MM Amonkar, ID Kalsekar, and JG Boyer
Ann Pharmacother 2002;36:605-611. DOI 10.1345/aph.1A309 [Abstract] [PDF] [Order Reprint]  

Headache education in colleges of pharmacy

RG Wenzel and MR Neidich
Ann Pharmacother 2002;36:612-616. DOI 10.1345/aph.1A336 [Abstract] [PDF] [Order Reprint]  

Effect of stress on international normalized ratio during warfarin therapy

TL Hawk and DE Havrda
Ann Pharmacother 2002;36:617-620. DOI 10.1345/aph.1A263 [Abstract] [PDF] [Order Reprint]  

Severe interaction between ritonavir and acenocoumarol

JM Llibre, J Romeu, E Lopez, and G Sirera
Ann Pharmacother 2002;36:621-623. DOI 10.1345/aph.19361 [Abstract] [PDF] [Order Reprint]  

Blood pressure elevation in a patient treated with salsalate

BB Phillips, JD Joss, and PL Mulhausen
Ann Pharmacother 2002;36:624-627. DOI 10.1345/aph.1A278 [Abstract] [PDF] [Order Reprint]  

Reversible thrombocytopenia associated with eptifibatide

M Yoder and RF Edwards
Ann Pharmacother 2002;36:628-630. DOI 10.1345/aph.1A218 [Abstract] [PDF] [Order Reprint]  

Cross-sensitivity between paroxetine and sertraline

CA Warnock and AG Azadian
Ann Pharmacother 2002;36:631-633. DOI 10.1345/aph.1A262 [Abstract] [PDF] [Order Reprint]  

Treatment of resistant depression by adding noradrenergic agents to lithium augmentation of SSRIs

R Ramasubbu
Ann Pharmacother 2002;36:634-640. DOI 10.1345/aph.10408 [Abstract] [PDF] [Order Reprint]  

Severe serotonin syndrome induced by mirtazapine monotherapy

JL Hernandez, FJ Ramos, J Infante, M Rebollo, and J Gonzalez-Macias
Ann Pharmacother 2002;36:641-643. DOI 10.1345/aph.1A302 [Abstract] [PDF] [Order Reprint]  

Neonatal cholestatic hepatitis from carbamazepine exposure during pregnancy and breast feeding

B Frey, CP Braegger, and D Ghelfi
Ann Pharmacother 2002;36:644-647. DOI 10.1345/aph.1A326 [Abstract] [PDF] [Order Reprint]  

New and emerging therapies for sepsis

DP Healy
Ann Pharmacother 2002;36:648-654. DOI 10.1345/aph.1A283 [Abstract] [PDF] [Order Reprint]  

Esomeprazole for acid peptic disorders

PB Kale-Pradhan, HK Landry, and WT Sypula
Ann Pharmacother 2002;36:655-663. DOI 10.1345/aph.1A104 [Abstract] [PDF] [Order Reprint]  

Risedronate for the prevention of fractures in postmenopausal osteoporosis

JM Sickels and CS Nip
Ann Pharmacother 2002;36:664-670. DOI 10.1345/aph.1A221 [Abstract] [PDF] [Order Reprint]  

Potential use of HMG-CoA reductase inhibitors for osteoporosis

LM Cushenberry and MR de Bittner
Ann Pharmacother 2002;36:671-678. DOI 10.1345/aph.1A072 [Abstract] [PDF] [Order Reprint]  

Pathophysiology and first-line treatment of osteoarthritis

JH Hogue and TL Mersfelder
Ann Pharmacother 2002;36:679-686. DOI 10.1345/aph.1A132 [Abstract] [PDF] [Order Reprint]  

Lidocaine-prilocaine cream versus tetracaine gel for procedural pain in children

A Taddio, MG Gurguis, and G Koren
Ann Pharmacother 2002;36:687-692. DOI 10.1345/aph.1A138 [Abstract] [PDF] [Order Reprint]  

Stereoselective pharmacokinetics and pharmacodynamics of anti-asthma agents

M Vakily, R Mehvar, and D Brocks
Ann Pharmacother 2002;36:693-701. DOI 10.1345/aph.1A248 [Abstract] [PDF] [Order Reprint]  

Low-dose ritonavir for protease inhibitor pharmacokinetic enhancement

RC Rathbun and DR Rossi
Ann Pharmacother 2002;36:702-706. DOI 10.1345/aph.1A202 [Abstract] [PDF] [Order Reprint]  

Serotonergic agents in the treatment of fibromyalgia syndrome

LJ Miller and KL Kubes
Ann Pharmacother 2002;36:707-712. DOI 10.1345/aph.1A184 [Abstract] [PDF] [Order Reprint]  

Fluoxetine in the treatment of premenstrual dysphoric disorder

RR Carr and MH Ensom
Ann Pharmacother 2002;36:713-717. DOI 10.1345/aph.1A265 [Abstract] [PDF] [Order Reprint]  

Pharmacist scope of practice: response to position paper

DR Hinthorn, JA Generali, and HN Godwin
Ann Pharmacother 2002;36:718-720. DOI 10.1345/aph.1C043 [PDF] [Order Reprint]  

A payment paradigm for pharmaceutical care

HM Rappaport
Ann Pharmacother 2002;36:721-725. DOI 10.1345/aph.1A276 [PDF] [Order Reprint]  

Local atrophy following steroid injection

JD Cleary
Ann Pharmacother 2002;36:726. DOI 10.1345/aph.1A318 [PDF] [Order Reprint]  

Erythropoietin use in a Jehovah's Witness patient

T Walton and EJ Macon
Ann Pharmacother 2002;36:729-730. DOI 10.1345/aph.1A352 [PDF] [Order Reprint]  

Severe rhabdomyolysis and cerivastatin-gemfibrozil combination therapy

B Roca, B Calvo, and R Monferrer
Ann Pharmacother 2002;36:730-731. DOI 10.1345/aph.1A383 [PDF] [Order Reprint]  

Comment: unbound drug concentration versus unbound drug fraction

MH Ensom
Ann Pharmacother 2002;36:731-732. DOI 10.1345/aph.1A034a [PDF] [Order Reprint]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.